Cargando…
Metformin: Focus on Melanoma
Metformin is the most common biguanide used in the treatment of diabetes, with 120 million treated patients worldwide. Metformin decreases hyperglycemia without inducing hypoglycemia in diabetic patients and is very well tolerated. The principal effects of metformin are to decrease hepatic gluconeog...
Autores principales: | Jaune, Emilie, Rocchi, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110909/ https://www.ncbi.nlm.nih.gov/pubmed/30186236 http://dx.doi.org/10.3389/fendo.2018.00472 |
Ejemplares similares
-
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
por: Ibrahim, Sherehan, et al.
Publicado: (2021) -
Metformin in Reproductive Biology
por: Faure, Melanie, et al.
Publicado: (2018) -
Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018) -
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies
por: Jaune, Emilie, et al.
Publicado: (2021) -
Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019)